Toggle navigation
Home
Search
Services
Blog
Contact
About
Medication Compliance Assistance System
Letzt, Alan
Adherence Technologies Corporation, Purcellville, VA, United States
Search 19 grants from Alan Letzt
Search grants from Adherence Technologies Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Oregon State Public Health Laboratory Participation in the FDA NARMS Retail Meat Program
Isl1 and Wntbeta-catenin regulation of cardiac progenitor cells
Pulmonary Benefits of Cystic Fibrosis Neonatal Screening
Ionizing Radiation Induced DNA Damage and Repair
Interstitial Microwave, Rf & Ferromagnetic Hyperthermia
Recently added grants:
The Impact of Tobacco Control Policies on Health Equity in the United States
Safer Approaches to CRC Chemoprevention
Exploring the shared genetic architecture of white blood cell variation and childhood acute lymphoblastic leukemia
DNA damage signaling to dormant origins of replication
Metabolic adaptation in lymphoid malignancies
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44AG010750-03
Application #
2051972
Study Section
Special Emphasis Panel (ZRG1-HUD-2 (01))
Program Officer
Helmers, Karin F
Project Start
1995-06-15
Project End
1998-05-31
Budget Start
1996-06-15
Budget End
1998-05-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Adherence Technologies Corporation
Department
Type
DUNS #
City
Purcellville
State
VA
Country
United States
Zip Code
20132
Related projects
NIH 1996
R44 AG
Medication Compliance Assistance System
Letzt, Alan / Adherence Technologies Corporation
NIH 1995
R44 AG
Medication Compliance Assistance System
Letzt, Alan / Adherence Technologies Corporation
Comments
Be the first to comment on this grant